The proposed molecular mechanisms responsible for the decline of metastatic tumors include reduction of the enzyme levels involved in invasion processes, such as MMPs, uPA, increase of the EMT markers, such as E-cadherin, or decrease of the MET markers, such as vimentin. This evidence concerns the gene CDH1 and metastatic neoplasm.